This inventor holds 1 USPTO granted patent. Top assignee: Pfizer Corporation. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Fabrice Henri Salingue: Innovator in Dopamine Agonist Research
Introduction
Fabrice Henri Salingue is a notable inventor based in Sandwich, GB. He has made significant contributions to the field of pharmacology, particularly in the development of novel compounds. His work focuses on dopamine agonists, which play a crucial role in treating various neurological conditions.
Latest Patents
Fabrice holds a patent for a salt form of a dopamine agonist, specifically 5-[(2R,5S)-5-methyl-4-propylmorpholin-2-yl]pyridin-2-amine. This invention pertains to the di-(1S)-camphorsulfonate form of this compound, known as di-S-camsylate. The patent details processes for the preparation of this salt, intermediates used in its synthesis, and its potential applications in medicinal formulations.
Career Highlights
Fabrice is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His role involves research and development of innovative therapeutic agents. His expertise in the field has contributed to advancements in drug formulation and delivery.
Collaborations
Fabrice has collaborated with esteemed colleagues, including Duncan Charles Miller and Stuart Peter Green. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Fabrice Henri Salingue is a prominent figure in the field of pharmacology, with a focus on dopamine agonists. His innovative work and collaborations continue to impact the development of new therapeutic agents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile